These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 37082203)

  • 1. A systematic review of genetic ancestry as a risk factor for incidence of non-small cell lung cancer in the US.
    James BA; Williams JL; Nemesure B
    Front Genet; 2023; 14():1141058. PubMed ID: 37082203
    [No Abstract]   [Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial Disparities in the Molecular Landscape of Cancer.
    Heath EI; Lynce F; Xiu J; Ellerbrock A; Reddy SK; Obeid E; Liu SV; Bollig-Fischer A; Separovic D; Vanderwalde A
    Anticancer Res; 2018 Apr; 38(4):2235-2240. PubMed ID: 29599344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ancestry-, Sex-, and Age-Based Differences of Gene Alterations in NSCLC: From the Real-World Data of Cancer Genomic Profiling Tests.
    Miura K; Shukuya T; Greenstein R; Kaplan B; Wakelee H; Kurokawa K; Furuta K; Kato S; Suh J; Sivakumar S; Sokol ES; Carbone DP; Takahashi K
    J Natl Compr Canc Netw; 2024 Aug; 22(7):. PubMed ID: 39116914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Signatures of
    Hsu J; Annunziata JF; Burns E; Bernicker EH; Olsen RJ; Thomas JS
    Clin Pathol; 2022; 15():2632010X221102054. PubMed ID: 35634237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic Signature of Driver Genes Identified by Target Next-Generation Sequencing in Chinese Non-Small Cell Lung Cancer.
    Wen S; Dai L; Wang L; Wang W; Wu D; Wang K; He Z; Wang A; Chen H; Zhang P; Dong X; Dong YA; Wang K; Yao M; Wang M
    Oncologist; 2019 Nov; 24(11):e1070-e1081. PubMed ID: 30902917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ancestry-associated co-alteration landscape of KRAS and EGFR-altered non-squamous NSCLC.
    Sisoudiya SD; Houle AA; Fernando T; Wilson TR; Schutzman JL; Lee J; Schrock A; Sokol ES; Sivakumar S; Shi Z; Pathria G
    NPJ Precis Oncol; 2024 Jul; 8(1):153. PubMed ID: 39033203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency of EGFR and KRAS mutations in patients with non small cell lung cancer by racial background: do disparities exist?
    Bauml J; Mick R; Zhang Y; Watt CD; Vachani A; Aggarwal C; Evans T; Langer C
    Lung Cancer; 2013 Sep; 81(3):347-353. PubMed ID: 23806795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Genetic Ancestry With the Molecular Subtypes and Prognosis of Childhood Acute Lymphoblastic Leukemia.
    Lee SHR; Antillon-Klussmann F; Pei D; Yang W; Roberts KG; Li Z; Devidas M; Yang W; Najera C; Lin HP; Tan AM; Ariffin H; Cheng C; Evans WE; Hunger SP; Jeha S; Mullighan CG; Loh ML; Yeoh AEJ; Pui CH; Yang JJ
    JAMA Oncol; 2022 Mar; 8(3):354-363. PubMed ID: 35084434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiologic Features of NSCLC Gene Alterations in Hispanic Patients from Puerto Rico.
    Zheng R; Yin Z; Alhatem A; Lyle D; You B; Jiang AS; Liu D; Jobbagy Z; Wang Q; Aisner S; Jiang JG
    Cancers (Basel); 2020 Nov; 12(12):. PubMed ID: 33255238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. STK11 and KEAP1 mutations in non-small cell lung cancer patients: Descriptive analysis and prognostic value among Hispanics (STRIKE registry-CLICaP).
    Cordeiro de Lima VC; Corassa M; Saldanha E; Freitas H; Arrieta O; Raez L; Samtani S; Ramos M; Rojas C; Burotto M; Chamorro DF; Recondo G; Ruiz-Patiño A; Más L; Zatarain-Barrón L; Mejía S; Nicolas Minata J; Martín C; Bautista Blaquier J; Motta Guerrero R; Aliaga-Macha C; Carracedo C; Ordóñez-Reyes C; Garcia-Robledo JE; Corrales L; Sotelo C; Ricaurte L; Santoyo N; Cuello M; Jaller E; Rodríguez J; Archila P; Bermudez M; Gamez T; Russo A; Viola L; Malapelle U; de Miguel Perez D; Rolfo C; Rosell R; Cardona AF
    Lung Cancer; 2022 Aug; 170():114-121. PubMed ID: 35753125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive genomic profiling of Brazilian non-small cell lung cancer patients (GBOT 0118/LACOG0418).
    Mascarenhas E; Gelatti AC; Araújo LH; Baldotto C; Mathias C; Zukin M; Werutsky G; Pacheco P; Gomes R; de Castro G; Cordeiro de Lima VC
    Thorac Cancer; 2021 Mar; 12(5):580-587. PubMed ID: 33314759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate Cancer Genomics: Recent Advances and the Prevailing Underrepresentation from Racial and Ethnic Minorities.
    Tan SH; Petrovics G; Srivastava S
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29690565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between West African ancestry with lung cancer risk and survival in African Americans.
    Mitchell KA; Shah E; Bowman ED; Zingone A; Nichols N; Pine SR; Kittles RA; Ryan BM
    Cancer Causes Control; 2019 Nov; 30(11):1259-1268. PubMed ID: 31468279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic Characterization of Non-Small-Cell Lung Cancer in African Americans by Targeted Massively Parallel Sequencing.
    Araujo LH; Timmers C; Bell EH; Shilo K; Lammers PE; Zhao W; Natarajan TG; Miller CJ; Zhang J; Yilmaz AS; Liu T; Coombes K; Amann J; Carbone DP
    J Clin Oncol; 2015 Jun; 33(17):1966-73. PubMed ID: 25918285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of TP53 concurrent mutations for EGFR- TKIs and ALK-TKIs based targeted therapy in advanced non-small cell lung cancer: a meta-analysis.
    Qin K; Hou H; Liang Y; Zhang X
    BMC Cancer; 2020 Apr; 20(1):328. PubMed ID: 32299384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation patterns in a population-based non-small cell lung cancer cohort and prognostic impact of concomitant mutations in KRAS and TP53 or STK11.
    La Fleur L; Falk-Sörqvist E; Smeds P; Berglund A; Sundström M; Mattsson JS; Brandén E; Koyi H; Isaksson J; Brunnström H; Nilsson M; Micke P; Moens L; Botling J
    Lung Cancer; 2019 Apr; 130():50-58. PubMed ID: 30885352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic abnormalities of the EGFR pathway in African American Patients with non-small-cell lung cancer.
    Leidner RS; Fu P; Clifford B; Hamdan A; Jin C; Eisenberg R; Boggon TJ; Skokan M; Franklin WA; Cappuzzo F; Hirsch FR; Varella-Garcia M; Halmos B
    J Clin Oncol; 2009 Nov; 27(33):5620-6. PubMed ID: 19786660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of oncogenic driver mutations in Hispanics/Latin patients with lung cancer. A systematic review and meta-analysis.
    Parra-Medina R; Pablo Castañeda-González J; Montoya L; Paula Gómez-Gómez M; Clavijo Cabezas D; Plazas Vargas M
    Lung Cancer; 2023 Nov; 185():107378. PubMed ID: 37729688
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.